E.U. to consider repackaging controls

Drug distributors who arbitrage the price differences across the European Union could see their $5.5 billion a year trade severely curtailed under proposed legislation set to be unveiled by the European Commission later this month. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.